Literature DB >> 35421322

The impact of obesity on the regulation of muscle blood flow during exercise in patients with heart failure with a preserved ejection fraction.

Stephen M Ratchford1,2, Joshua F Lee1,2, Kanokwan Bunsawat1,2, Jeremy K Alpenglow3, Jia Zhao1, Christy L Ma4, John J Ryan4, Lillian L Khor4, D Walter Wray1,2,3.   

Abstract

Obesity is now considered a primary comorbidity in heart failure with preserved ejection fraction (HFpEF) pathophysiology, mediated largely by systemic inflammation. Although there is accumulating evidence for a disease-related dysregulation of blood flow during exercise in this patient group, the role of obesity in the hemodynamic response to exercise remains largely unknown. Small muscle mass handgrip (HG) exercise was used to evaluate exercising muscle blood flow in nonobese (BMI < 30 kg/m2, n = 14) and obese (BMI > 30 kg/m2, n = 40) patients with HFpEF. Heart rate (HR), stroke index (SI), cardiac index (CI), mean arterial pressure (MAP), forearm blood flow (FBF), and vascular conductance (FVC) were assessed during progressive intermittent HG exercise [15%-30%-45% maximal voluntary contraction (MVC)]. Blood biomarkers of inflammation [C-reactive protein (CRP) and interleukin-6 (IL-6)] were also determined. Exercising FBF was reduced in obese patients with HFpEF at all work rates (15%: 304 ± 42 vs. 229 ± 15 mL/min; 30%: 402 ± 46 vs. 300 ± 18 mL/min; 45%: 484 ± 55 vs. 380 ± 23 mL/min, nonobese vs. obese, P = 0.025), and was negatively correlated with BMI (R = -0.47, P < 0.01). In contrast, no differences in central hemodynamics (HR, SI, CI, and MAP) were found between groups. Proinflammatory biomarkers were markedly elevated in patients with obesity (CRP: 2,133 ± 418 vs. 4,630 ± 590 ng/mL, P = 0.02; IL-6: 2.9 ± 0.3 vs. 5.2 ± 0.7 pg/mL, nonobese vs. obese, P = 0.04), and both biomarkers were positively correlated with BMI (CRP: R = 0.40, P = 0.03; IL-6: R = 0.57, P < 0.01). Together, these findings demonstrate the presence of obesity and an accompanying milieu of systemic inflammation as important factors in the dysregulation of exercising muscle blood flow in patients with HFpEF.NEW & NOTEWORTHY Obesity is the primary comorbid condition in HFpEF pathophysiology, but the role of adiposity on the peripheral circulation is not well understood. The present study identified a 30%-40% reduction in forearm blood flow during handgrip exercise, accompanied by a marked elevation in proinflammatory plasma biomarkers, in obese patients with HFpEF compared with their nonobese counterparts. These findings suggest an exaggerated dysregulation in exercising muscle blood flow associated with the obese HFpEF phenotype.

Entities:  

Keywords:  exercise hyperemia; heart failure; inflammation; preserved ejection fraction; vasodilation

Mesh:

Substances:

Year:  2022        PMID: 35421322      PMCID: PMC9126213          DOI: 10.1152/japplphysiol.00833.2021

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  60 in total

1.  Secretion of MCP-1 and IL-6 by cytokine stimulated production of reactive oxygen species in endothelial cells.

Authors:  T Volk; M Hensel; H Schuster; W J Kox
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

2.  The importance of Doppler angle of insonation on differentiation between 50-69% and 70-99% carotid artery stenosis.

Authors:  K Logason; T Bärlin; M L Jonsson; A Boström; H G Hårdemark; S Karacagil
Journal:  Eur J Vasc Endovasc Surg       Date:  2001-04       Impact factor: 7.069

Review 3.  cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance.

Authors:  Guadalupe Sabio; Roger J Davis
Journal:  Trends Biochem Sci       Date:  2010-05-07       Impact factor: 13.807

4.  Heart failure with a normal ejection fraction: is it really a disorder of diastolic function?

Authors:  Daniel Burkhoff; Mathew S Maurer; Milton Packer
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

Review 5.  Non-invasive pulsatile arterial pressure and stroke volume changes from the human finger.

Authors:  Lysander W J Bogert; Johannes J van Lieshout
Journal:  Exp Physiol       Date:  2005-03-31       Impact factor: 2.969

Review 6.  New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function.

Authors:  Michael R Zile; Dirk L Brutsaert
Journal:  Circulation       Date:  2002-03-19       Impact factor: 29.690

Review 7.  Obesity-Related Heart Failure With a Preserved Ejection Fraction: The Mechanistic Rationale for Combining Inhibitors of Aldosterone, Neprilysin, and Sodium-Glucose Cotransporter-2.

Authors:  Milton Packer; Dalane W Kitzman
Journal:  JACC Heart Fail       Date:  2018-03-07       Impact factor: 12.035

Review 8.  Microvascular dysfunction: an emerging pathway in the pathogenesis of obesity-related insulin resistance.

Authors:  Dennis M J Muris; Alfons J H M Houben; Miranda T Schram; Coen D A Stehouwer
Journal:  Rev Endocr Metab Disord       Date:  2013-03       Impact factor: 6.514

Review 9.  Microvascular responsiveness in obesity: implications for therapeutic intervention.

Authors:  Zsolt Bagi; Attila Feher; James Cassuto
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

10.  Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance.

Authors:  M Laakso; S V Edelman; G Brechtel; A D Baron
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.